|
1
|
Uccelli A, Moretta L and Pistoia V:
Mesenchymal stem cells in health and disease. Nat Rev Immunol.
8:726–736. 2008. View
Article : Google Scholar
|
|
2
|
Zaidi M: Skeletal remodeling in health and
disease. Nat Med. 13:791–801. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang W, Yang S, Shao J and Li YP:
Signaling and transcriptional regulation in osteoblast commitment
and differentiation. Front Biosci. 12:3068–3092. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karsenty G, Kronenberg HM and Settembre C:
Genetic control of bone formation. Annu Rev Cell Dev Biol.
25:629–648. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baum R and Gravallese EM: Impact of
inflammation on the osteoblast in rheumatic diseases. Curr
Osteoporos Rep. 12:9–16. 2014. View Article : Google Scholar :
|
|
6
|
Walsh NC and Gravallese EM: Bone
remodeling in rheumatic disease: a question of balance. Immunol
Rev. 233:301–312. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Walsh NC, Reinwald S, Manning CA, et al:
Osteoblast function is compromised at sites of focal bone erosion
in inflammatory arthritis. J Bone Miner Res. 24:1572–1585. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cenci S, Weitzmann MN, Roggia C, et al:
Estrogen deficiency induces bone loss by enhancing T-cell
production of TNF-alpha. J Clin Invest. 106:1229–1237. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roggia C, Gao Y, Cenci S, et al:
Up-regulation of TNF-producing T cells in the bone marrow: a key
mechanism by which estrogen deficiency induces bone loss in vivo.
Proc Natl Acad Sci USA. 98:13960–13965. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Canalis E: Effects of tumor necrosis
factor on bone formation in vitro. Endocrinology. 121:1596–1604.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gilbert L, He X, Farmer P, et al:
Inhibition of osteoblast differentiation by tumor necrosis
factor-alpha. Endocrinology. 141:3956–3964. 2000.PubMed/NCBI
|
|
12
|
Li Y, Li A, Strait K, Zhang H, Nanes MS
and Weitzmann MN: Endogenous TNFalpha lowers maximum peak bone mass
and inhibits osteoblastic Smad activation through NF-kappaB. J Bone
Miner Res. 22:646–655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang J, Wang Z, Tang E, et al: Inhibition
of osteoblastic bone formation by nuclear factor-kappaB. Nat Med.
15:682–689. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Locksley RM, Killeen N and Lenardo MJ: The
TNF and TNF receptor superfamilies: integrating mammalian biology.
Cell. 104:487–501. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dempsey PW, Doyle SE, He JQ and Cheng G:
The signaling adaptors and pathways activated by TNF superfamily.
Cytokine Growth Factor Rev. 14:193–209. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Novack DV: Role of NF-κB in the skeleton.
Cell Res. 21:169–182. 2011. View Article : Google Scholar
|
|
17
|
Kular J, Tickner J, Chim SM and Xu J: An
overview of the regulation of bone remodelling at the cellular
level. Clin Biochem. 45:863–873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Raggatt LJ and Partridge NC: Cellular and
molecular mechanisms of bone remodeling. J Biol Chem.
285:25103–25108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Wu HF, Ang ES, et al: NF-kappaB
modulators in osteolytic bone diseases. Cytokine Growth Factor Rev.
20:7–17. 2009. View Article : Google Scholar
|
|
20
|
Scharf DH, Heinekamp T, Remme N,
Hortschansky P, Brakhage AA and Hertweck C: Biosynthesis and
function of gliotoxin in Aspergillus fumigatus. Appl Microbiol
Biotechnol. 93:467–472. 2012. View Article : Google Scholar
|
|
21
|
Kupfahl C, Ruppert T, Dietz A, Geginat G
and Hof H: Candida species fail to produce the immunosuppressive
secondary metabolite gliotoxin in vitro. FEMS Yeast Res. 7:986–992.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kosalec I, Puel O, Delaforge M, et al:
Isolation and cytotoxicity of low-molecular-weight metabolites of
Candida albicans. Front Biosci. 13:6893–6904. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sutton P, Newcombe NR, Waring P and
Müllbacher A: In vivo immunosuppressive activity of gliotoxin, a
metabolite produced by human pathogenic fungi. Infect Immun.
62:1192–1198. 1994.PubMed/NCBI
|
|
24
|
Pahl HL, Krauss B, Schulze-Osthoff K, et
al: The immuno-suppressive fungal metabolite gliotoxin specifically
inhibits transcription factor NF-kappaB. J Exp Med. 183:1829–1840.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kroll M, Arenzana-Seisdedos F, Bachelerie
F, Thomas D, Friguet B and Conconi M: The secondary fungal
metabolite gliotoxin targets proteolytic activities of the
proteasome. Chem Biol. 6:689–698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
López-Franco O, Suzuki Y, Sanjuán G, et
al: Nuclear factor-kappa B inhibitors as potential novel
anti-inflammatory agents for the treatment of immune
glomerulonephritis. Am J Pathol. 161:1497–1505. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hur JM, Yun HJ, Yang SH, Lee WY, Joe MH
and Kim D: Gliotoxin enhances radiotherapy via inhibition of
radiation-induced GADD45a, p38 and NFkappaB activation. J Cell
Biochem. 104:2174–2184. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goldring SR and Gravallese EM:
Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin
Rheumatol. 12:195–199. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Krum SA, Chang J, Miranda-Carboni G and
Wang CY: Novel functions for NFkappaB: inhibition of bone
formation. Nat Rev Rheumatol. 6:607–611. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Soysa NS and Alles N: NF-kappaB functions
in osteoclasts. Biochem Biophys Res Commun. 378:1–5. 2009.
View Article : Google Scholar
|
|
32
|
Ozaki K, Takeda H, Iwahashi H, Kitano S
and Hanazawa S: NF-kappaB inhibitors stimulate apoptosis of rabbit
mature osteoclasts and inhibit bone resorption by these cells. FEBS
Lett. 410:297–300. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Trebec-Reynolds DP, Voronov I, Heersche JN
and Manolson MF: VEGF-A expression in osteoclasts is regulated by
NF-kappaB induction of HIF-1alpha. J Cell Biochem. 110:343–351.
2010.PubMed/NCBI
|
